致癌与突变杂志

案例报告

Oxaliplatin Plus S1 for Treating Sorafenib-Refractory Recurrent Hepatocellular Carcinoma after Liver Transplantation

• Jing Suna, Xiaomin Caia, Wei Lia, Meiling Zhanga, Jing Hea, Qian Wanga and Kaihua Lua

研究文章

Use of E18 Cell Model to Quantify DNA Strand Break Associated Bystander Effect (DSB-ABE)

• Jalal Nasir

评论文章

Soluble Epoxide Hydrolase: Potential Target for Inflammation and Inflammation-Driven Cancer

• Chao Lou, Liping Zhang, Xiaobing Wang, Xiaoping Ma, Cuiyun Qin, Wei Li, Ting Jia, Qing Nan and Rong Qiang

研究文章

Characterization of a Novel Cell Line (HCH-3) Derived from a Human Ovarian Clear Cell Carcinoma

• Takashi Yamada, Kimiaki Hattori, Hidetoshi Satomi, Tadashi Okazaki, Hiroshi Mori and Yoshinobu Hirose

评论文章

Development of Anti-Cancer Stem Cells as Theranostic Agents in the Treatment of Different Cancer Types: An Update

• Arif Malik, Rabia Rasool, Saima Rubab Khan, Sulayman Waquar, Javed Iqbal, Syed Saeed Ul- Hassan, Mahmood Husain Qazi and Aamer Qazi

研究文章

Risk of Prostate Cancer and Cyclin D1 A870G polymorphism; a Study of Correlation

• Firdous Hussain, Arif Hamid and Rita Singh Majumdhar